Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Caremark/CVS May Be Better For Brand Drug Firms Than PBM Consolidation

Executive Summary

Brand pharmaceutical companies may prefer a Caremark/CVS merger to a Caremark/Express Scripts combination

You may also be interested in...

Express Scripts Makes Hostile Bid For Caremark, But Faces CVS, FTC Hurdles

Express Scripts will work to characterize the pharmacy benefit management marketplace as being composed of more players than the "big three" independent PBMs in attempting to secure Federal Trade Commission clearance of its proposed acquisition of Caremark, CEO George Paz indicated

CVS/Caremark May Have Less Formulary Adherence, Express Scripts Says

CVS/Caremark's intention to be "agnostic" to whether prescriptions are filled by mail or retail could adversely affect the proposed entity's ability to manage members' formulary adherence, Express Scripts VP-Investor Relations David Myers suggested

CVS/Caremark Declares Mail V. Retail Truce; Will New Model Win The Peace?

The marriage of CVS and Caremark will blur the lines between traditional mail order and retail pharmacy services by providing a range of prescription dispensing options




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts